CDMP
Network-owned
Address
104 Carnegie Center Suite 300
Princeton, New Jersey 08540
Web Address
Year Founded
1998
Parent Company
Omnicom Health
Web Address
Full-time Employees
65
Number of Clients
12
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
2
Locations
Princeton, NJ
San Francisco
Executives & Senior Management
Senior Management
Sharon Callahan
CEO
Craig Romanok
President
Gretchen Eberhart, MD
Executive Vice President, Director of Strategic Services
Gary Scheiner
Executive Vice President, Executive Creative Director
Deb Goldberg
Executive Vice President, Director of Client Services
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Med-ed
Med-Tech
Public Health
Data/Analytics
Digital
New Services
We recently hired Michael Austin, Chief Experience Officer (CXO), as a new central role within the CDM network. The CXO will inspire, build, and activate customer experience strategies to deliver differentiated brand experiences that drive customer loyalty and advocacy. This new practice is a connector between our strategy, creative, technology, data, and analytics teams, with the remit of creating customer engagement in the moments that matter and develop personalized, cross-channel solutions with the individual in mind. Amplifying that capability is the hire of our own head of Customer Engagement at CDMP, Peter DeLorenzo. Peter's background in data-heavy CRM, digital, and omnichannel is exactly what our clients need to maximize their spend and create meaningful, lasting, and impactful customer interactions at every touch point. Another area of growth for us is in social. We are finding more and more clients embracing and activating Digital Opinion Leaders, and our social team is masterful at identifying the most appropriate, onboarding and training them, and co-creating the most relevant and authentic content with them.
Client Roster
Abbott Point of Care – i-STAT Alinity TBI Plasma Test
BioMarin – gene therapy
BioMarin – Hemophilia
BioMarin - PKU Bristol
Bristol Myers Squibb – myeloid
SK Life Science – Xcopri
Sun Pharmaceuticals – Ilumya
Teva – Bendeka
Teva – Granix
Teva – Truxima
Sage/Biogen – MDD Emerging
Biotechnology - Corporate Identity/Pipeline Development
Growth
2021 Growth from Existing Clients
5%
2021 Growth from New Clients
12%
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Managing growth
Payer-related challenges
Pricing-related issues
Keeping up with pace of innovation
Replenishing new-business pipeline
Procurement-related issues
Network relationships/agency consolidation
Shrinking pharma budgets
Further diversification of services
Regulatory concerns
Pandemic-related disruptions
Need for private equity/capital infusion
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Working from home
Ongoing fallout from pandemic
Ongoing fallout from societal unrest
Creative Samples